USE OF IL-23 AND IL-17 ANTIAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140248279A1
SERIAL NO

14274905

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME CORPRAHWAY NJ 07065-0907

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caspi, Rachel Bethesda, US 7 55
Cua, Daniel J Boulder Creek, US 28 281
Kastelein, Robert A Redwood City, US 106 1083
Luger, Dror Rockville, US 7 53
Silver, Phyllis Silver Spring, US 6 54
Tsai, Van T San Diego, US 9 60

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation